AbbVie Inc. (ABBV34)

Profile

https://www.abbvie.com

AbbVie Inc. is a prominent biopharmaceutical company dedicated to the research, development, and distribution of innovative medicines and treatments globally. Established in 2013 as a spin-off from Abbott Laboratories, AbbVie focuses on addressing complex and serious health conditions, with core areas of expertise in immunology, oncology, virology, and neuroscience. The company is renowned for its development of the blockbuster drug Humira, which has been used to treat autoimmune diseases such as rheumatoid arthritis. Additionally, AbbVie has made significant strides in oncology with its acquisition of Allergan in 2020, enhancing its product portfolio with treatments for conditions like chronic migraines. AbbVie's strategic approach combines cutting-edge research with a patient-centric model, aiming to improve the quality of life for those affected by severe illnesses. As a key player in the pharmaceutical sector, AbbVie holds a significant role in advancing healthcare innovations, contributing to industry growth, and addressing unmet medical needs.